ArticleJournal for immunotherapy of cancer2020

Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study.

Leylah Drusbosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.